In contrast to previous reports of a critical role for IDO or IL-12 pathways in the suppressive effect of MDSCs in tumor models [27], [39], we did not identify the requirement for these pathways in the suppressive effect of IMCs from non-tumor-bearing mice on T-cell proliferation. The gene discussed is IDO1; the disease is neoplasm.